Document Detail

Current aspects of correction of neurohumoral system activity in patients after myocardial infarction.
MedLine Citation:
PMID:  23222698     Owner:  NLM     Status:  In-Data-Review    
Acute myocardial infarction is still considered as one of the most threatening disorders in internal medicine. Numerous complications of infarction develop due to activation of different neurohumoral systems. The article discusses modern methods of pharmacological correction of neurohumoral system activity in various stages of myocardial infarction. It is emphasized that current guidelines do not always allow to effectively prevent left ventricular remodeling. New drugs used for this aim are discussed.
Valentin A Kokorin; Andrey A Spassky; Nikolai A Volov; Ilya A Kokorin
Related Documents :
385998 - Simple method for measurement of cardiac output by thermodilution after cardiac operation.
3530048 - Continuous noninvasive monitoring of cardiac output with esophageal doppler ultrasound ...
12569328 - Simultaneous cardiac output and regional myocardial perfusion determination with pet an...
20093268 - Mathematical modelling to identify patients who should not undergo left ventricle remod...
20957858 - Cardiac mri in obs lowers admissions.
17149678 - Acute heart failure due to fulminant and giant cell myocarditis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Polskie Archiwum Medycyny Wewnętrznej     Volume:  122 Suppl 1     ISSN:  1897-9483     ISO Abbreviation:  Pol. Arch. Med. Wewn.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401225     Medline TA:  Pol Arch Med Wewn     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  47-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics.
Next Document:  Differential analysis of gene regulation at transcript resolution with RNA-seq.